Societal Issues arising from Synthetic Biology: What Lies Ahead. A Department of Energy & Alfred P. Sloan Foundation Workshop Report

Similar documents
Responsible innovation and synthetic biology. Prof Phil Macnaghten Knowledge, Technology and Innovation Wageningen University (NL)

Interoperable systems that are trusted and secure

Emerging Technologies: What Have We Learned About Governing the Risks?

Learning Goals and Related Course Outcomes Applied To 14 Core Requirements

Emerging and Readily Available Technologies and National Security: A Framework for Addressing Ethical, Legal, and Societal Issues

Our position. ICDPPC declaration on ethics and data protection in artificial intelligence

THEME 4: FLEXIBILITY (TORRITI, READING)

Report on the Results of. Questionnaire 1

Bridging Research and Policy on Climate Change and Conflict

European Commission. 6 th Framework Programme Anticipating scientific and technological needs NEST. New and Emerging Science and Technology

Translational scientist competency profile

Hackathons as a Source of Entrepreneurship in Corporations

New science new dilemmas

Theme: Global Visions and Local Practices Development Research in a Post-2015 World

ART AS A WAY OF KNOWING

The Method Toolbox of TA. PACITA Summer School 2014 Marie Louise Jørgensen, The Danish Board of Technology Foundation

Cover Page. The handle holds various files of this Leiden University dissertation.

Committee on Development and Intellectual Property (CDIP)

Committee on Development and Intellectual Property (CDIP)

BIG IDEAS. Personal design choices require self-exploration, collaboration, and evaluation and refinement of skills. Learning Standards

Science Impact Enhancing the Use of USGS Science

Social Innovation and new pathways to social changefirst insights from the global mapping

Training TA Professionals

EXPLORING HOW ENGINEERING ENTREPRENEURSHIP COMPETENCIES ALIGN WITH ABET CRITERION 3A-K

Scientific Integrity at the AGU: What is it? Tim Killeen Director, National Center for Atmospheric Research President, American Geophysical Union

COUNTRY: Questionnaire. Contact person: Name: Position: Address:

European Circular Economy Stakeholder Conference Brussels, February 2018 Civil Society Perspectives

United Nations Framework Convention on Climate Change UNFCCC EXPERT GROUP ON TECHNOLOGY TRANSFER FIVE YEARS OF WORK

in the New Zealand Curriculum

Emerging biotechnologies. Nuffield Council on Bioethics Response from The Royal Academy of Engineering

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:

Access to Medicines, Patent Information and Freedom to Operate

Sociotechnical Imaginaries in Research and Innovation Policy

OECD Innovation Strategy: Key Findings

ENGR. (MRS.) FUNMILADE AKINGBAGBOHUN FNIMechE,MNSE THE ROLE OF ENGINEERS IN NATIONAL ECONOMY DEVELOPMENT.

Concept of Periodic Synthesis Report

The 45 Adopted Recommendations under the WIPO Development Agenda

EXPLORATION DEVELOPMENT OPERATION CLOSURE

Medical Innovation Changing Business Models. Geneva, 5 July 2013

SECOND GLOBAL SYMPOSIUM ON HEALTH SYSTEMS RESEARCH SCIENCE TO ACCELERATE UNIVERSAL HEALTH COVERAGE

Constants and Variables in 30 Years of Science and Technology Policy. Luke Georghiou University of Manchester Presentation for NISTEP 30 Symposium

Cross Disciplinary Research and the Role of Industry.

Written Statement of. Dr. Sandra Magnus Executive Director American Institute of Aeronautics and Astronautics Reston, Virginia

Committee on Development and Intellectual Property (CDIP)

Society Science Society Science

Revised East Carolina University General Education Program

TRIPS, FTAs and BITs: Impact on Domestic IP- and Innovation Strategies in Developing Countries

Academic Vocabulary Test 1:

Summary of the. World Café. at the EUROSYNBIO Conference Cannes Mandelieu May

Non-cancer effects: science and values aspects of protection decisions

NOTE BY THE DIRECTOR GENERAL STATUS OF THE FOLLOW-UP TO THE RECOMMENDATIONS ON SCIENCE AND TECHNOLOGY MADE TO THE THIRD REVIEW CONFERENCE

General Education Rubrics

Science-Policy Review

The Intergovernmental Platform on Biodiversity and Ecosystem Services (IPBES)

Research strategy

Towards a Consumer-Driven Energy System

GENEVA COMMITTEE ON DEVELOPMENT AND INTELLECTUAL PROPERTY (CDIP) Fifth Session Geneva, April 26 to 30, 2010

Design and technology

PBL Challenge: DNA Microarray Fabrication Boston University Photonics Center

PBL Challenge: Of Mice and Penn McKay Orthopaedic Research Laboratory University of Pennsylvania

3rd SCAR Foresight. XXIV EURAGRI Members Conference 2010 Broadening the Agricultural Challenges to Green Growth. Helsinki, 6 7 September 2010

THEME 4 Creating Innovative Approaches to Local and Global Challenges

WIPO: Working on the balance

Faculty of Humanities and Social Sciences

Roadmap Pitch: Road2CPS - Roadmapping Project Platforms4CPS Roadmap Workshop

Establishing a Development Agenda for the World Intellectual Property Organization

Enacting Transformative Innovation Policy: A Comparative Study

DESIGN INSTITUTE OF AUSTRALIA ABN GPO Box 355 Melbourne, VIC 3001

Managing & Communicating Knowledge in Three States

Engaged and responsible universities shaping Europe

WIPO Development Agenda

United Nations Principles

Science of Science & Innovation Policy (SciSIP) Julia Lane

The Gibraltar Financial Services Commission. Experienced Investor Fund Directors Thematic Review Outcomes

Judith A. O'Brien Director, Keystone Energy Program and Strategic Partnerships

Capstone Design. The Law of Unintended Consequences

Arie Rip (University of Twente)*

December Eucomed HTA Position Paper UK support from ABHI

Ontario Elementary Curriculum Connections to Active Safe, Sustainable Transportation (2016)

President Barack Obama The White House Washington, DC June 19, Dear Mr. President,

IEEE IoT Vertical and Topical Summit - Anchorage September 18th-20th, 2017 Anchorage, Alaska. Call for Participation and Proposals

Committee on Development and Intellectual Property (CDIP)

SHORT SUMMARY REPORT OF THE WORKSHOP ON GENETIC INVENTIONS, INTELLECTUAL PROPERTY RIGHTS AND LICENSING PRACTICES

Support for Universities and R&D institutions

General Assembly. United Nations A/63/411. Information and communication technologies for development. I. Introduction. Report of the Second Committee

Colombia s Social Innovation Policy 1 July 15 th -2014

Inclusively Creative

Refining foresight approaches to crisis, inertia and transition

Priority Theme 1: Science, Technology and Innovation (STI) for the Post-2015 Agenda


Report to Congress regarding the Terrorism Information Awareness Program

Question Q 159. The need and possible means of implementing the Convention on Biodiversity into Patent Laws

AN ETHICAL FRAMEWORK FOR HUMAN AUGMENTATION. Moderator and Author NADJA OERTELT

Empirical Research on Systems Thinking and Practice in the Engineering Enterprise

SCAR response to the 2 nd Foresight Expert Group Report

Higher Education Institutions and Responsible Research and Innovation. Prof. Ana Marušić, MD PhD

National Workshop on Responsible Research & Innovation in Australia 7 February 2017, Canberra

Radiological Protection: Old Questions Needing New Answers

Metrics and Methodologies for Assessment of Proliferation Risk

Energy Technology Roadmaps

Transcription:

Societal Issues arising from Synthetic Biology: What Lies Ahead A Department of Energy & Alfred P. Sloan Foundation Workshop Report

Workshop Objectives! Workshop organized by DOE and Alfred P. Sloan Foundation hosted by the Woodrow Wilson Center! Bring together synthetic biologists, policy makers, ethicists and social scientists to look forward and anticipate with a broad view what might happen to applications of synthetic biology in the future

Workshop Structure & Methodology Prior distribution of paper on systemic risks, disruptive technologies and implications for governance Participant response to pre-workshop questions Are there lessons learned from the introduction of past technologies that may be pertinent to synthetic biology? Have you experienced or encountered any situations or conversations that presented you with any challenges arising from synthetic biology and society? What urgent ELSI research needs, arising synthetic biology, can you suggest? from

Plenary presentations: synthetic biologist, historical perspective on ELSI research Presentations of DOE and Sloan Foundation grantees working on societal impacts of synthetic biology Focused breakout groups: likely first uses of synthetic biology and attendant societal issues legal, public policy, and communication issues that may be expected to arise from synthetic biology research and applications Gap analysis: knowledge gaps that could contribute to a research agenda going forward

Meeting Synopsis Breakout session 1: What are the potential uses and applications of synthetic biology? What are the potential game changers (both inside/directly related to the science and technology, and outside)? Breakout session 2: Legal and economic: controlling information like material? biopiracy intellectual property - SB as a thing vs. a toolkit Societal and public policy issues: provision of objective information about underlying science needed input from wide range of communities initiatives required to bridge gap between communities of scientists, journalists, ethicists, those working in public policy Public understanding and engagement: common understanding of what SB is needed open discussion of potential benefits and risks paternalistic approaches to engagement not meaningful

Meeting Synthesis Definitional issues: What constitutes synthetic biology and who belongs to the community of synthetic biology practitioners? Public engagement/communication to multiple publics, including religious groups, challenges articulated by practitioners What might a game changer look like in synthetic biology? New fuels, applications to human microbiome, environmental release, first success/ first failure How should synthetic biology be regulated? How should it be funded? Can welfare concerns be part of the regulatory process? Regulatory and IP laws/approaches and their economics and social impacts need to be studied. How can ELSI be meaningfully used? Embedded or integrated? Measurable contributions? How can communication be fostered?

Gap analysis What important issues or questions do you think still need to be addressed in the field of synthetic biology as they relate to societal issues? Legal and Economic IP related Public Policy Public Engagement and Communication

Legal/Economic Anticipatory/adaptive governance and/or regulation - how to govern a fast-moving technology whose future directions, risks and impacts cannot be predicted in advance How to incorporate social, ethical, religious concerns into governance or regulatory structures? What should government involvement look like? Who should make decisions about what research directions to pursue? How should the DIY bio community be monitored/ regulated? How do we assess and frame progress (with metrics) in overcoming issues?

Intellectual Property Are there IP-related issues peculiar to synthetic biology and can (or should) the current patent system be altered to address them? What IP regimes for new disruptive technologies have worked best (in terms of technology dissemination, economic return, fairness) in the past and can we learn from them for synthetic biology? Is open source biology a better business model than alternatives involving more restriction? Does the current IP regime affect synthetic biology research in a way that promotes innovation or constrains it? How can the apparent historical conflicts between life scientists approach to IP and ownership and engineers approach to IP and ownership be resolved to the benefit of society?

Public Policy Should the products/outcomes of synthetic biology be tagged or labeled so as to clearly identify their method of manufacture? How important is this for public acceptance? For potential synthetic biology applications that are intended to have an enduring effect (e.g., changing human microbiome, an environmental application, production of synbiofuel) instead of a short-term applications (flu vaccine, etc.) - how might one ensure the intended effects are achieved and unintended consequences are benign (or limited) in changing systems (aging humans, ecosystems etc.)? How best can we educate decision-makers (policy-makers, Congress, judges) about synthetic biology and more generally the culture of science? What do they need to know and who should influence the development of this curriculum? Can we come up with a clearer definition (of synthetic biology?)

Public engagement and communication How can the case for synthetic biology ELSI be forcefully, convincingly, persuasively stated - why it matters, why it is important? What are creative mechanisms for engaging both the public and the social and ethical synthetic biology communities in dialogue about opportunities/needs/values? How can the risk assessment process better engage the publics differing views/values concerning risk? Can we foster an interdisciplinary deep dive on ethical and conceptual assumptions/ foundations of risk estimation and evaluations? With regard to synthetic biology communications what should be communicated to whom (and why) and who decides?

Please Add to this List On-line survey at: http://www.synbioproject.org/events/archive/ what_lies_ahead/

Questions? Comments?